174 results on '"Wilson, Frederick H."'
Search Results
2. Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Clinical Activity and Mechanisms of Resistance
3. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
4. Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Clinical Activity and Mechanisms of Resistance
5. WNK3 Kinase Is a Positive Regulator of NKCC2 and NCC, Renal $Cation-Cl^-$ Cotransporters Required for Normal Blood Pressure Homeostasis
6. A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA
7. Paracellular Cl- Permeability Is Regulated by WNK4 Kinase: Insight into Normal Physiology and Hypertension
8. WNK4 Regulates Apical and Basolateral Cl - Flux in Extrarenal Epithelia
9. WNK1, a Kinase Mutated in Inherited Hypertension with Hyperkalemia, Localizes to Diverse Cl - -Transporting Epithelia
10. Molecular Pathogenesis of Inherited Hypertension with Hyperkalemia: The Na-Cl Cotransporter Is Inhibited by Wild-Type but Not Mutant WNK4
11. Human Hypertension Caused by Mutations in WNK Kinases
12. Supplementary Data from RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
13. Supplementary Table from RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
14. Supplementary Figure from RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
15. Suppl. Figure S3 from Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non–Small Cell Lung Cancer
16. Suppl. Table S1 from Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non–Small Cell Lung Cancer
17. Data from Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non–Small Cell Lung Cancer
18. Supplementary Methods from Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non–Small Cell Lung Cancer
19. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
20. Genetic modifiers of EGFR dependence in non-small cell lung cancer
21. RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
22. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells
23. WNK4 Regulates Activity of the Epithelial Na⁺ Channel in vitro and in vivo
24. An SGK1 Site in WNK4 Regulates Na⁺ Channel and K⁺ Channel Activity and Has Implications for Aldosterone Signaling and K⁺ Homeostasis
25. CANCER THERAPY: MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
26. Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
27. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-[Cl.sup.-] cotransporters required for normal blood pressure homeostasis
28. Contributors
29. The Syndrome of Hypertension and Hyperkalemia (Pseudohypoaldosteronism Type II)
30. Regulation of diverse ion transport pathways by WNK4 kinase: a novel molecular switch
31. The social and economic history of Ostia
32. Larotrectinib in NTRK-Rearranged Solid Tumors
33. WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1)
34. Larotrectinib in NTRK-Rearranged Solid Tumors
35. Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non–Small Cell Lung Cancer
36. ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway Activation
37. Abstract IA24: PRMT5 as a therapeutic target inMTAP-deleted cancers
38. The So-Called "Magazzini Repubblicani" near the Porta Romana at Ostia
39. Studies in the Social and Economic History of Ostia: Part I
40. Studies in the Social and Economic History of Ostia: Part II
41. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study
42. Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter
43. A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
44. Administration of Vincristine in a Patient with Machado-Joseph Disease
45. An SGK1 site in WNK4 regulates Na + channel and K + channel activity and has implications for aldosterone signaling and K + homeostasis
46. WNK4 regulates activity of the epithelial Na + channel in vitro and in vivo
47. WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+channel ROMK1 (Kir1.1)
48. WNK kinases: molecular regulators of integrated epithelial ion transport
49. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion
50. WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl − -transporting epithelia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.